Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
about
Magnesium in Prevention and TherapyLack of influence of serum magnesium levels on overall mortality and cardiovascular outcomes in patients with advanced chronic kidney disease.Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerabilityThe role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.Magnesium and FGF-23 are independent predictors of pulse pressure in pre-dialysis diabetic chronic kidney disease patients.Low Magnesium Levels and FGF-23 Dysregulation Predict Mitral Valve Calcification as well as Intima Media Thickness in Predialysis Diabetic PatientsThe relationship between proton pump inhibitor use and serum magnesium concentration among hemodialysis patients: a cross-sectional study.Serum Magnesium and Sudden Death in European Hemodialysis PatientsContribution of dysregulated serum magnesium to mortality in hemodialysis patients with secondary hyperparathyroidism: a 3-year cohort studyHypomagnesemia and Mortality in Incident Hemodialysis PatientsLower serum magnesium is associated with vascular calcification in peritoneal dialysis patients: a cross sectional study.Essential Nutrient Interactions: Does Low or Suboptimal Magnesium Status Interact with Vitamin D and/or Calcium Status?Proton pump inhibitors use in hemodialysis patients and serum magnesium levelsSerum Magnesium and the Risk of Death From Coronary Heart Disease and Sudden Cardiac DeathSevelamer carbonate reduces the risk of hypomagnesemia in hemodialysis-requiring end-stage renal disease patientsReduced Mortality in Maintenance Haemodialysis Patients on High versus Low Dialysate Magnesium: A Pilot Study.The effect of magnesium supplementation on vascular calcification in chronic kidney disease-a randomised clinical trial (MAGiCAL-CKD): essential study design and rationale.Proton Pump Inhibitors: More Indigestion than Relief?Magnesium reduces calcification in bovine vascular smooth muscle cells in a dose-dependent manner.Effect of a magnesium-based phosphate binder on medial calcification in a rat model of uremiaMagnesium and outcomes in patients with chronic kidney disease: focus on vascular calcification, atherosclerosis and survival.Association of hypermagnesemia and blood pressure in the critically ill.Oral Magnesium Supplementation in Chronic Kidney Disease Stages 3 and 4: Efficacy, Safety, and Effect on Serum Calcification Propensity-A Prospective Randomized Double-Blinded Placebo-Controlled Clinical Trial.Ionized and total serum magnesium in hemodialysis: predictors and variability. A longitudinal cross-sectional study.Evaluation of the Predictive Value of the Serum Calcium-Magnesium Ratio for All-Cause and Cardiovascular Mortality in Incident Dialysis Patients.Magnesium Replacement to Protect Cardiovascular and Kidney Damage? Lack of Prospective Clinical Trials.Serum Magnesium after Kidney Transplantation: A Systematic Review.Routine hemodialysis induces a decline in plasma magnesium concentration in most patients: a prospective observational cohort study.
P2860
Q26781293-5278DA61-4778-41A8-9BF8-A9ECBE4482F7Q33710843-1888293C-6D65-4FD2-BDDE-0A58B2A89E3FQ34213692-A9078442-A3AE-4BAF-A74A-705EF21EC021Q34533678-6339E252-12E8-4909-B994-FD87ABD4A5ECQ35227631-30EAA175-D595-4FBE-9AE7-57C3474E580EQ35671325-3E2DC2DE-5DAF-44C4-BEE9-57528846DEF3Q35744487-F6BAD2E7-704E-4EC9-876D-2DDC23B1078AQ35850564-A3552A01-A99B-447A-B111-BBD9603BC7FBQ36306782-CFB5FCAF-C691-4CF1-AC17-BDC4573880DBQ36315868-035626EA-180D-4B56-8789-2A31177F2630Q36338922-ED5446AA-4335-4ADB-A844-72EB4AC36D2AQ36476938-0D9F688E-84E7-4777-B073-B89680217233Q36493276-798FF4DE-6547-4F9C-B1A2-DD4667887A07Q36877779-2C3DBA61-D4A8-48A2-8FC3-4A286B0C32F0Q36951232-8330CFDB-34A7-4F45-A57E-C7B177F749C1Q38612718-318A6736-6907-4B71-8350-6F3FD5B9D7B5Q38711321-473A316A-471C-46F0-B230-0E4ACF13293DQ39152043-F6C2F010-FC9B-45A0-ADC6-0F15188A15E5Q40963199-F6E4E50B-6C98-4C95-BA2F-BA704F729ED0Q42142326-D9795EB6-0BCB-4628-98E0-6F552E6E4F56Q42718947-0B445DEC-FCCD-4D9F-A85F-3E47FCEFB0CCQ43885609-9A4A67F2-E02B-4F17-BED0-3A9A588B5BA1Q47100824-472297D5-7754-4B42-A6C8-E50F68BB8C5AQ47584614-068DA4BD-455D-4381-A2FC-611FAF8359E0Q49987850-DFF2033A-CA68-4B2C-97F3-AF56BCD177BEQ54963847-7FA066CA-A31E-4B48-9CCC-AD64BA84F6A5Q55447877-C374E5E8-D204-4233-AB0E-9170972E99D3Q55649866-D2A42668-CE8E-443B-8C05-FF8861070DF3
P2860
Serum magnesium concentration is a significant predictor of mortality in maintenance hemodialysis patients.
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Serum magnesium concentration ...... tenance hemodialysis patients.
@ast
Serum magnesium concentration ...... tenance hemodialysis patients.
@en
Serum magnesium concentration ...... tenance hemodialysis patients.
@nl
type
label
Serum magnesium concentration ...... tenance hemodialysis patients.
@ast
Serum magnesium concentration ...... tenance hemodialysis patients.
@en
Serum magnesium concentration ...... tenance hemodialysis patients.
@nl
prefLabel
Serum magnesium concentration ...... tenance hemodialysis patients.
@ast
Serum magnesium concentration ...... tenance hemodialysis patients.
@en
Serum magnesium concentration ...... tenance hemodialysis patients.
@nl
P2093
P1433
P1476
Serum magnesium concentration ...... ntenance hemodialysis patients
@en
P2093
Eiji Ishimura
Masaaki Inaba
Senji Okuno
Tomoyuki Yamakawa
Yoshiki Nishizawa
P304
P577
2007-12-01T00:00:00Z